Search for: "Thomas A. Matthews"
Results 101 - 120
of 1,531
Sort by Relevance
|
Sort by Date
5 May 2023, 4:00 am
But Thomas did not cover the bill. [read post]
5 May 2023, 3:17 am
Matthew Luxmoore and Laurence Norman report for the Wall Street Journal. [read post]
4 May 2023, 3:04 am
Will Vernon and Thomas Spender report for BBC News. [read post]
30 Apr 2023, 9:05 pm
Included were: Sarah Sorscher, Center for Science in the Public Interest; Thomas Gremillion, Consumer Federation of America; Brian Ronholm, Consumer Reports; Scott Faber, Environmental Working Group; Mitzi Baum, Stop Foodborne Illness; Amanda Craten, Consumer Federation of America; Vanessa Coffman, STOP Foodborne Illness; Shrinidhi (Nidhi) Joshi, STOP Foodborne Illness; Craig Hedberg, University of Minnesota; John Glenn Morris, University of Florida; Martin… [read post]
26 Apr 2023, 2:43 am
Farnoush Amiri, Matthew Lee, Aamer Madhani and Lolita C. [read post]
22 Apr 2023, 3:32 am
District Judge Matthew Kacsmaryk in Texas invalidated the Food and Drug Administration’s approval of mifepristone despite its availability for many years. [read post]
21 Apr 2023, 4:50 pm
Justice Clarence Thomas did not elaborate on his reasoning, but Justice Samuel Alito penned a four-page dissent in which he questioned the need for the court to act now. [read post]
21 Apr 2023, 4:05 pm
The court did not explain its reasoning, but noted that Justices Clarence Thomas and Samuel Alito dissented. [read post]
20 Apr 2023, 8:29 am
The ruling, issued by Judge Matthew Kacsmaryk, would prevent millions of people nationwide from accessing mifepristone. [read post]
17 Apr 2023, 4:18 pm
Clarence Thomas Isn't The Only One Not Fully Disclosing: Get a look at Matthew Kacsmaryk. [read post]
17 Apr 2023, 5:50 am
The new Easter legal term begins this week on Tuesday 18 April 2023 and finishes on Friday 26 May 2023. [read post]
14 Apr 2023, 9:08 am
District Judge Matthew Kacsmaryk agreed with the plaintiffs, finding that the FDA approved the use of mifepristone despite “legitimate safety concerns. [read post]
14 Apr 2023, 4:00 am
Clarence Thomas and the Billionaire ProPublica – Joshua Kaplan, Justin Elliott, and Alex Mierjeski | Published: 4/6/2023 Supreme Court Justice Clarence Thomas accepted luxury trips around the globe for more than two decades, including travel on a superyacht and private jet, from a prominent Republican donor without disclosing them. [read post]
12 Apr 2023, 11:39 am
Matthew Eckstein $12 Million Ponzi Scheme Former Financial Advisor Matthew Eckstein was sentenced in July 2022 to up to ten-and-a-half years in prison for his role in a $12 million Ponzi scheme that targeted nearly 50 victims—many of them seniors—between 2015 and 2017. [read post]
12 Apr 2023, 6:33 am
Judge Matthew Kacsmaryk of the U.S. [read post]
12 Apr 2023, 4:22 am
Thomas Grove reports for the Wall Street Journal. [read post]
11 Apr 2023, 3:48 am
Matthew Luxmoore reports for the Wall Street Journal. [read post]
9 Apr 2023, 11:29 am
Texas District Judge Matthew Kacsmaryk wrote that the “FDA acquiesced on its legitimate safety concerns—in violation of its statutory duty—based on plainly unsound reasoning and studies that did not support its conclusions. [read post]
7 Apr 2023, 6:30 am
Fisch (University of Pennsylvania Carey School of Law) and Jeff Schwartz (University of Utah) , on Monday, April 3, 2023 Tags: corporate democracy, disclosure requirements, Fiduciary duties, Institutional voting, Intermediaries, pass-through voting, Shareholders Pay Versus Performance Disclosure – Findings from the Early S&P 500 Filers Posted by Kelly Malafis, John Swift, and Matthew Schwarcz, Compensation Advisory Partners, on Monday, April 3, 2023 Tags: Compensation… [read post]
7 Apr 2023, 6:30 am
Fisch (University of Pennsylvania Carey School of Law) and Jeff Schwartz (University of Utah) , on Monday, April 3, 2023 Tags: corporate democracy, disclosure requirements, Fiduciary duties, Institutional voting, Intermediaries, pass-through voting, Shareholders Pay Versus Performance Disclosure – Findings from the Early S&P 500 Filers Posted by Kelly Malafis, John Swift, and Matthew Schwarcz, Compensation Advisory Partners, on Monday, April 3, 2023 Tags: Compensation… [read post]
